Test Price
2,800 AED✅ Home Collection Available
KCNJ1 Gene Bartter Syndrome Type 2 Genetic Test in UAE | AED 2,800 | DHA Licensed
Executive Summary & Core Metrics
This advanced genetic test using Next-Generation Sequencing (NGS) technology provides 99.9% diagnostic accuracy for detecting mutations causing Bartter syndrome type 2, adhering to the highest quality and privacy standards approved by the Dubai Health Authority and Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed genetic counsellors for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Genetic Test comprehensively analyses the KCNJ1 gene to diagnose Bartter syndrome type 2, a rare renal tubular disorder causing life-threatening electrolyte imbalances in infants and children. Early genetic confirmation enables targeted intervention and genetic counselling.
| Feature | Our Test: KCNJ1 NGS | Closest Alternative: Targeted Sanger Sequencing |
|---|---|---|
| Precision | 99.9% analytical sensitivity, all exons & splice sites | Limited to known hotspots; may miss novel variants |
| Method | Illumina NovaSeq™ NGS with CNV calling | Capillary electrophoresis |
| Turnaround | 3–4 Weeks | 2–3 Weeks (may require reflex to full gene) |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I understand the anxiety families face when awaiting a genetic diagnosis for a critically ill child. This NGS test provides definitive confirmation of Bartter syndrome type 2, enabling targeted electrolyte management and genetic counselling for future pregnancies. Correlation with clinical presentation and biochemical markers remains essential."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Medication Advisory
Do not discontinue prescribed medication (e.g., potassium supplements, spironolactone, indomethacin) without consulting your doctor. Abrupt cessation can trigger life-threatening hypokalaemia or arrhythmia.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Acute febrile illness; inability to provide adequate blood or DNA sample; refusal to sign informed consent (mandatory for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Emergency Red Flags: Seek immediate medical attention if you or your child experience severe muscle weakness, paralysis, palpitations, irregular heartbeat, tetany, or collapse—these may indicate critical hypokalaemia (<2.5 mmol/L).
Patient FAQ & Clinical Guidance
1. What is the KCNJ1 gene Bartter syndrome type 2 DNA test, and why is it necessary?
A: This NGS test detects pathogenic mutations in the KCNJ1 gene responsible for Bartter syndrome type 2, a severe salt-wasting nephropathy presenting in the neonatal period with life-threatening dehydration and electrolyte disturbances.
2. How is the sample collected for this genetic test in the UAE, and is a hospital visit required?
A: A certified phlebotomist collects a small blood sample (2–5 mL in EDTA tube) or a finger-prick dried blood spot on an FTA card via our home collection service, eliminating the need for hospital travel.
3. Will my UAE health insurance cover the AED 2,800 cost for the KCNJ1 genetic test?
A: Many UAE insurers cover medically necessary genetic testing when accompanied by a specialist referral; we provide direct billing verification via WhatsApp before your appointment to confirm coverage.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Regulatory Compliance
This genetic test is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is stored and processed exclusively within the UAE under strict confidentiality protocols. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Licensed Facility No. 1143.
Clinical & Logistical Metadata
| Test Name | KCNJ1 Gene Bartter Syndrome Type 2 Genetic Test |
| Price (AED) | AED 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina NovaSeq™ with CNV calling |
| ICD-10-CM Code | E26.81 |
| LOINC Code | 69040-7 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians